$CATX
Perspective Therapeutics Inc

2024 Q2 Form 10-Q Financial Statement

#000095017024060427 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $526.0K $325.0K $2.063M
YoY Change -74.81% -84.25% -29.11%
Cost Of Revenue $1.576M
YoY Change 7.28%
Gross Profit $487.0K
YoY Change -66.2%
Gross Profit Margin 23.61%
Selling, General & Admin $5.514M $5.878M $7.835M
YoY Change -7.85% -24.98% 245.46%
% of Gross Profit 1608.83%
Research & Development $9.275M $7.452M $3.857M
YoY Change 64.07% 93.21% 602.55%
% of Gross Profit 791.99%
Depreciation & Amortization $572.0K $346.0K $180.0K
YoY Change 120.0% 92.22% 143.24%
% of Gross Profit 36.96%
Operating Expenses $14.79M $13.33M $11.71M
YoY Change 27.25% 13.8% 315.83%
Operating Profit -$14.26M -$13.01M -$11.23M
YoY Change 25.4% 15.84% 715.92%
Interest Expense $3.049M $1.180M $18.00K
YoY Change 10789.29% 6455.56% -37.93%
% of Operating Profit
Other Income/Expense, Net $3.049M $1.180M $356.0K
YoY Change 1037.69% 231.46% 1127.59%
Pretax Income -$11.21M -$11.83M -$10.87M
YoY Change 0.97% 8.78% 707.05%
Income Tax $0.00 -$10.50M
% Of Pretax Income
Net Earnings -$11.70M -$12.28M -$371.0K
YoY Change 5.38% 3211.05% -72.46%
Net Earnings / Revenue -2225.1% -3779.69% -17.98%
Basic Earnings Per Share -$0.18 -$0.02 $0.00
Diluted Earnings Per Share -$0.18 -$0.02 $0.00
COMMON SHARES
Basic Shares Outstanding 622.6M 586.9M 228.6M
Diluted Shares Outstanding 66.65M 495.1M 228.6M

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $292.9M $180.6M $36.50M
YoY Change 934.87% 394.93% -38.03%
Cash & Equivalents $252.0M $142.1M $36.45M
Short-Term Investments $40.87M $38.53M $0.00
Other Short-Term Assets $1.226M $6.553M $1.000M
YoY Change -12.43% 555.3% 81.49%
Inventory $1.408M
Prepaid Expenses
Receivables $142.0K $999.0K $1.400M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $294.2M $188.2M $40.27M
YoY Change 820.81% 367.39% -35.84%
LONG-TERM ASSETS
Property, Plant & Equipment $14.75M $14.30M $6.733M
YoY Change 109.39% 112.42% 247.96%
Goodwill $24.06M $24.10M $27.32M
YoY Change -11.92% -11.78%
Intangibles $50.00M
YoY Change
Long-Term Investments
YoY Change
Other Assets $672.0K $482.0K $567.0K
YoY Change 17.28% -14.99% 472.73%
Total Long-Term Assets $91.68M $90.09M $87.38M
YoY Change 3.96% 3.1% 2504.44%
TOTAL ASSETS
Total Short-Term Assets $294.2M $188.2M $40.27M
Total Long-Term Assets $91.68M $90.09M $87.38M
Total Assets $385.9M $278.3M $127.6M
YoY Change 221.21% 118.02% 93.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.127M $6.027M $3.900M
YoY Change 25.04% 54.54% 407.15%
Accrued Expenses $3.029M $1.956M $3.200M
YoY Change -15.86% -38.88% 169.59%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $54.00K $50.00K $100.0K
YoY Change -46.0% -50.0%
Total Short-Term Liabilities $10.61M $14.50M $7.194M
YoY Change 23.53% 101.6% 267.79%
LONG-TERM LIABILITIES
Long-Term Debt $1.651M $1.663M $1.700M
YoY Change -2.88% -2.18%
Other Long-Term Liabilities $19.00K $27.64M $700.0K
YoY Change -98.42% 3848.14% -26.78%
Total Long-Term Liabilities $19.00K $29.30M $2.400M
YoY Change -99.34% 1120.83% 151.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.61M $14.50M $7.194M
Total Long-Term Liabilities $19.00K $29.30M $2.400M
Total Liabilities $44.92M $48.40M $9.617M
YoY Change 290.9% 403.22% 230.25%
SHAREHOLDERS EQUITY
Retained Earnings -$176.4M -$164.7M -$106.3M
YoY Change 50.27% 54.93% 10.14%
Common Stock $517.4M $394.6M $224.3M
YoY Change 128.89% 75.91% 40.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $341.0M $229.9M $118.0M
YoY Change
Total Liabilities & Shareholders Equity $385.9M $278.3M $127.6M
YoY Change 221.21% 118.02% 93.07%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$11.70M -$12.28M -$371.0K
YoY Change 5.38% 3211.05% -72.46%
Depreciation, Depletion And Amortization $572.0K $346.0K $180.0K
YoY Change 120.0% 92.22% 143.24%
Cash From Operating Activities -$8.902M $13.85M -$9.723M
YoY Change 10.17% -242.43% 583.76%
INVESTING ACTIVITIES
Capital Expenditures $1.015M $9.072M $201.0K
YoY Change 78.07% 4413.43% -873.08%
Acquisitions
YoY Change
Other Investing Activities -$2.280M -$38.23M $25.46M
YoY Change -250.14%
Cash From Investing Activities -$3.295M -$47.30M $25.26M
YoY Change 478.07% -287.23% -97261.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 122.1M 166.3M -$80.00K
YoY Change 23838.04% -208010.0%
NET CHANGE
Cash From Operating Activities -8.902M 13.85M -$9.723M
Cash From Investing Activities -3.295M -47.30M $25.26M
Cash From Financing Activities 122.1M 166.3M -$80.00K
Net Change In Cash 109.9M 132.9M $15.46M
YoY Change -1449.96% 759.56% -1167.61%
FREE CASH FLOW
Cash From Operating Activities -$8.902M $13.85M -$9.723M
Capital Expenditures $1.015M $9.072M $201.0K
Free Cash Flow -$9.917M $4.776M -$9.924M
YoY Change 14.65% -148.13% 610.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000728387
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-33407
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
PERSPECTIVE THERAPEUTICS, INC.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1458152
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2401 Elliott Avenue, Suite 320
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Seattle
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98121
CY2024Q1 dei City Area Code
CityAreaCode
206
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
676-0900
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
CY2024Q1 dei Trading Symbol
TradingSymbol
CATX
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NYSEAMER
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
622629038
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
142117000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9238000
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
38531000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
0
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
650000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
650000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
999000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1165000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1287000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1133000
CY2024Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
5266000
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
5301000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
188200000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
16837000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14302000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5576000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1058000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
747000
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
182000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
182000
CY2024Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
50000000
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
50000000
CY2024Q1 us-gaap Goodwill
Goodwill
24062000
CY2023Q4 us-gaap Goodwill
Goodwill
24062000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
482000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
487000
CY2024Q1 us-gaap Assets
Assets
278286000
CY2023Q4 us-gaap Assets
Assets
97891000
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6027000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6909000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
128000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
46000
CY2024Q1 catx Accrued Personnel Expenses Current
AccruedPersonnelExpensesCurrent
1828000
CY2023Q4 catx Accrued Personnel Expenses Current
AccruedPersonnelExpensesCurrent
3588000
CY2024Q1 us-gaap Notes Payable Current
NotesPayableCurrent
50000
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
49000
CY2024Q1 us-gaap Deferred Income Current
DeferredIncomeCurrent
1400000
CY2023Q4 us-gaap Deferred Income Current
DeferredIncomeCurrent
0
CY2024Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
5070000
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
5072000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
14503000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
15664000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1037000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
780000
CY2024Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
1663000
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
1676000
CY2024Q1 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
26600000
CY2023Q4 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
0
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4592000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4592000
CY2024Q1 us-gaap Liabilities
Liabilities
48395000
CY2023Q4 us-gaap Liabilities
Liabilities
22712000
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
586915977
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
586915977
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
281809852
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
281809852
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
587000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
282000
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
394028000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
227337000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-164724000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-152440000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
229891000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
75179000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
278286000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
97891000
CY2024Q1 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
325000
CY2023Q1 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
233000
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7452000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3309000
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5878000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6663000
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-22000
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
13330000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
9994000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-13005000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-9761000
CY2024Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1211000
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
374000
CY2024Q1 catx Interest And Other Expense
InterestAndOtherExpense
29000
CY2023Q1 catx Interest And Other Expense
InterestAndOtherExpense
18000
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1180000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
356000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11825000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9405000
CY2024Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-461000
CY2023Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-1466000
CY2024Q1 catx Gain Loss Recognized On Classification As Held For Sale
GainLossRecognizedOnClassificationAsHeldForSale
2000
CY2023Q1 catx Gain Loss Recognized On Classification As Held For Sale
GainLossRecognizedOnClassificationAsHeldForSale
0
CY2024Q1 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-12284000
CY2023Q1 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-10871000
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-10500000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-12284000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-371000
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.02
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.02
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.01
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.01
CY2024Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0
CY2024Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0
CY2023Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.01
CY2023Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.01
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
495100000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
495100000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228591000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
228591000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-12284000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-371000
CY2023Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
CY2024Q1 catx Proceeds From Prefunded Warrants Net
ProceedsFromPrefundedWarrantsNet
10208000
CY2023Q1 catx Proceeds From Prefunded Warrants Net
ProceedsFromPrefundedWarrantsNet
0
CY2024Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
CY2024Q1 catx Noncash Expense Lease
NoncashExpenseLease
28000
CY2023Q1 catx Noncash Expense Lease
NoncashExpenseLease
1000
CY2024Q1 us-gaap Depreciation
Depreciation
346000
CY2023Q1 us-gaap Depreciation
Depreciation
180000
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-22000
CY2024Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
10000
CY2023Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
10000
CY2024Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
0
CY2023Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
9000
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0
CY2024Q1 catx Accrued Interest On Short Term Investments
AccruedInterestOnShortTermInvestments
306000
CY2023Q1 catx Accrued Interest On Short Term Investments
AccruedInterestOnShortTermInvestments
0
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
656000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1368000
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-10500000
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-166000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1000
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-27000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-128000
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
154000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
60000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-883000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-588000
CY2024Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
28000000
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0
CY2024Q1 catx Increase Decrease In Accrued Personnel Expenses
IncreaseDecreaseInAccruedPersonnelExpenses
-1760000
CY2023Q1 catx Increase Decrease In Accrued Personnel Expenses
IncreaseDecreaseInAccruedPersonnelExpenses
79000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
13848000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9723000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9072000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
201000
CY2024Q1 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
38225000
CY2023Q1 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
0
CY2024Q1 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
0
CY2023Q1 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
22764000
CY2024Q1 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0
CY2023Q1 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
2699000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-47297000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
25262000
CY2024Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
12000
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
15000
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
126000
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2024Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
53141000
CY2023Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
65000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
166328000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-80000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
132879000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
15459000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9420000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21175000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
142299000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
36634000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
142117000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36452000
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
182000
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
182000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
142299000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
36634000
CY2024Q1 catx Recognition Of Operating Lease Liability And Right Of Use Asset
RecognitionOfOperatingLeaseLiabilityAndRightOfUseAsset
348000
CY2023Q1 catx Recognition Of Operating Lease Liability And Right Of Use Asset
RecognitionOfOperatingLeaseLiabilityAndRightOfUseAsset
0
CY2024Q1 catx Noncash Or Part Noncash Acquisition Value Of Assets Acquired Including Goodwill
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquiredIncludingGoodwill
0
CY2023Q1 catx Noncash Or Part Noncash Acquisition Value Of Assets Acquired Including Goodwill
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquiredIncludingGoodwill
85885000
CY2023Q1 us-gaap Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Shares Issued1
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1
136545075
CY2024Q1 us-gaap Stock Issued1
StockIssued1
0
CY2023Q1 us-gaap Stock Issued1
StockIssued1
54618000
CY2024Q1 catx Noncash Or Part Noncash Acquisition Assumption Of Stock Options And Warrants
NoncashOrPartNoncashAcquisitionAssumptionOfStockOptionsAndWarrants
0
CY2023Q1 catx Noncash Or Part Noncash Acquisition Assumption Of Stock Options And Warrants
NoncashOrPartNoncashAcquisitionAssumptionOfStockOptionsAndWarrants
-7836000
CY2024Q1 catx Noncash Or Part Noncash Acquisition Notes Receivable And Accrued Interest Forgiven
NoncashOrPartNoncashAcquisitionNotesReceivableAndAccruedInterestForgiven
0
CY2023Q1 catx Noncash Or Part Noncash Acquisition Notes Receivable And Accrued Interest Forgiven
NoncashOrPartNoncashAcquisitionNotesReceivableAndAccruedInterestForgiven
-6171000
CY2024Q1 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
348000
CY2023Q1 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
17260000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
54642000
CY2023Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
54553000
CY2023Q1 catx Adjustments To Additional Paid In Capital Assumption Of Stock Options And Warrants At Fair Value
AdjustmentsToAdditionalPaidInCapitalAssumptionOfStockOptionsAndWarrantsAtFairValue
7836000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1368000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-371000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
118028000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
75179000
CY2024Q1 catx Adjustments To Additional Paid In Capital Issuance Of Pre Funded Warrants
AdjustmentsToAdditionalPaidInCapitalIssuanceOfPreFundedWarrants
10208000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
126000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
656000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-12284000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
229891000
CY2024Q1 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
180600000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-164700000
CY2024Q1 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
180600000
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reclassifications</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition to the discontinued operations discussed above, the Company has made certain reclassifications to prior period amounts in the condensed consolidated financial statements and accompanying notes to conform to the current period presentation. The reclassification of these items had no impact on net loss, financial position or cash flows in the current or prior periods. Specifically, accrued payroll and related taxes and accrued vacation were combined to create accrued personnel, and accrued protocol expense and accrued waste disposal are included in accounts payable and accrued expenses, all of which are presented on the condensed consolidated balance sheets and condensed consolidated statement of cash flows.</span></p>
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
56035000
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
43903000
CY2023Q4 catx Maximum Amount Of Securities Offer And Sale
MaximumAmountOfSecuritiesOfferAndSale
200000000
CY2024Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
CY2023Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15317000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6245000
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1015000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
669000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14302000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5576000
CY2024Q1 us-gaap Goodwill
Goodwill
24100000
CY2023Q4 us-gaap Goodwill
Goodwill
24100000
CY2024Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
50000000
CY2024Q1 catx Indefinitelived Intangible Assets Accumulated Amortization
IndefinitelivedIntangibleAssetsAccumulatedAmortization
0
CY2024Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
50000000
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
50000000
CY2023Q4 catx Indefinitelived Intangible Assets Accumulated Amortization
IndefinitelivedIntangibleAssetsAccumulatedAmortization
0
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
50000000
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
0
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
622000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
982000
CY2024Q1 us-gaap Loss Contingency Number Of Plaintiffs
LossContingencyNumberOfPlaintiffs
6
CY2023Q4 catx Aggregate Maximum Estimate Settlement Amount
AggregateMaximumEstimateSettlementAmount
200000
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y7M6D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
147000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
329000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
324000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
320000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
283000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1403000
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
238000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1165000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
128000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1037000
CY2024Q1 catx Estimated Hazardous Waste Removal Liability
EstimatedHazardousWasteRemovalLiability
500000
CY2023Q4 catx Estimated Hazardous Waste Removal Liability
EstimatedHazardousWasteRemovalLiability
500000
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
37000
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
52000
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
55000
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1569000
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
1713000
CY2023Q1 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
317000
CY2023Q1 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-6674000
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 catx Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
CY2024Q1 catx Non Rule10 B51 Arrangement Modified Flag
NonRule10B51ArrangementModifiedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000950170-24-060427-index-headers.html Edgar Link pending
0000950170-24-060427-index.html Edgar Link pending
0000950170-24-060427.txt Edgar Link pending
0000950170-24-060427-xbrl.zip Edgar Link pending
catx-20240331.htm Edgar Link pending
catx-20240331.xsd Edgar Link pending
catx-ex31_1.htm Edgar Link pending
catx-ex31_2.htm Edgar Link pending
catx-ex31_3.htm Edgar Link pending
catx-ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
catx-20240331_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending